ESC issues policy statement on reperfusion therapy

November 28, 2005

Sophia Antipolis, France, 25 November 2005: A pivotal influence on patient outcome in ST-segment elevation myocardial infarction (STEMI), reperfusion therapy is the most important component of STEMI treatment. A paper by the ESC on its policy with regard to this topic will be published online today in the European Heart Journal, an official journal of the ESC1.

A clinician may utilise various types of reperfusion, including thrombolytic treatment, percutaneous coronary intervention (PCI), or a combination thereof. Despite this, the paper notes that many countries do not sufficiently implement reperfusion therapy, and as a result, many patients with STEMI do not receive such therapy. For this reason, the ESC decided to review pharmacological and mechanical reperfusion strategies to identify obstacles and find solutions for its implementation.

During a two-day policy conference in June 2005, opinion leaders involved in reperfusion therapy gathered to discuss this issue2. Attendees included authors of existing guidelines, experts in reperfusion therapy from throughout Europe and North America, and representatives of national societies of cardiology and ESC working groups. From this policy conference, opinion leaders came up with several messages for the cardiology community:Mobilization of the cardiology community with the involvement of health authorities can improve the rate of reperfusion therapy offered to patients. The ESC aims to contribute to this goal in a joint effort with its member national societies.
1. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Jean-Pierre Bassand, N. Danchin, G. Filippatos, A. Gitt, C. Hamm, S. Silber, M. Tubaro and F. Weidinger. European Heart Journal, doi:10.1093/eurheartj/ehi673.
2. The Policy Conference was held on Friday 24 and Saturday 25 June 2005, at the European Heart House, the ESC headquarters in Sophia Antipolis, France.

The European Heart Journal is an official journal of the European Society of Cardiology. Please acknowledge the journal as a source in any articles. Paper available on request.

The European Society of Cardiology (ESC)

The European Society of Cardiology (ESC) represents more than 45,000 cardiology professionals across Europe and the Mediterranean. Its mission is to improve the quality of life of the European population by reducing the impact of cardiovascular disease.

The ESC achieves this through a variety of scientific and educational activities including the coordination of: clinical practice guidelines, education courses and initiatives, pan-European surveys on specific disease areas and the ESC Annual Congress, the largest medical meeting in Europe. Furthermore, the ESC promotes cardiovascular disease prevention messages to the general public, most notably during its annual 'For Your Heart's Sake' event, a fun yet educational event offering risk assessment and prevention advice, held in parallel to the Congress each year.

The ESC comprises 2 Councils, 4 Associations, 23 Working Groups and 49 National Cardiac Societies. Both the ESC Congress and 'For Your Heart's Sake' take place in late August/early September each year in a European 'Heart-Healthy City'. The World Congress of Cardiology 2006, to be held from 2-6 September in Barcelona, Spain, will be a unique occasion bringing together the ESC Congress 2006 and the World Heart Federation's XVth World Congress of Cardiology.

The ESC administrative headquarters are based at the European Heart House, Sophia Antipolis, France. For more information on the ESC, Congress and initiatives, see

European Society of Cardiology

Related Cardiology Articles from Brightsurf:

Cardiology compensation continues to rise; new interventional measures reported
MedAxiom, an American College of Cardiology Company and the premier source for cardiovascular organizational performance solutions, has released its eighth annual Cardiovascular Provider Compensation and Production Survey.

50% drop in patients attending cardiology services during coronavirus lockdown
The number of NHS patients presenting to cardiology services for serious heart problems more than halved while the number of heart attacks diagnosed fell by 40% at one centre in Scotland during the coronavirus lockdown, finds research published in the online journal Open Heart.

American College of Cardiology issues clinical competencies for cardiovascular NPs, PAs
The American College of Cardiology has released the 2020 Clinical Competencies for Nurse Practitioners and Physician Assistants in Adult Cardiovascular Medicine, identifying the knowledge and skills that are important for nurse practitioners (NPs) and physician assistants (PAs) working in general cardiovascular medicine and cardiovascular medicine subspecialty areas.

Scientists find potential way to defuse 'time bomb' of cardiology
In a new study published in EBioMedicine, researchers at Western University and Lawson Health Research Institute use principles from cancer biology to demonstrate what might be causing aortic aneurysms and potentially how to treat them.

Multimodality imaging training for general and advanced cardiology fellowships
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp.

One-two punch helps solve greatest unmet need in cardiology
Combining a high-fat diet with a drug that raises blood pressure gave UT Southwestern researchers a 'two-hit' model, like a one-two punch to heart failure.

Digital, mobile advances will define future of cardiology
The future of cardiovascular care will be transformed by advances in artificial intelligence, digital health technology, and mobile as a means to prevent and treat heart disease, according to several review articles published today in a Journal of the American College of Cardiology Focus Seminar on the Future Technology of Cardiovascular Care.

St. Michael's Hospital cardiology team reports a world first
Interventional cardiologist Dr. Neil Fam of St. Michael's Hospital has performed a world-first procedure, which he described in the Feb, 26 issue of the Journal of the American College of Cardiology: Cardiovascular Interventions.

The 28th Great Wall International Congress of Cardiology, Beijing, China
The 28th Great Wall International Congress of Cardiology (GW-ICC), the Asia Pacific Heart Congress (APHC) 2017, and the International Congress of Cardiovascular Prevention and Rehabilitation 2017 is being held from October 12th to 15th at the China National Convention Center (CNCC), Beijing, China.

Large nuclear cardiology laboratory slashes radiation dose by 60 percent in 8 years
A large nuclear cardiology laboratory has slashed its average radiation dose by 60 percent in eight years, according to new research presented today at ICNC 2017 and published in JACC: Cardiovascular Imaging.

Read More: Cardiology News and Cardiology Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to